Atlas Trials

Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

Clinical trial NCT05465434 · COMPLETED

Trial details

NCT number
NCT05465434
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2022-08-01
Primary completion
2023-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.